Local infusion of an α-1 adrenergic agonist into the prefrontal cortex impairs spatial working memory performance in monkeys

BACKGROUND Stimulation of alpha-2 adrenoceptors in the monkey or rat prefrontal cortex (PFC) has been known to improve spatial working memory (SWM) and stimulation of alpha-1 adrenoceptors in the rat PFC has been reported to impair SWM. The present study attempted to replicate in monkey the rat experiments on alpha-1 adrenoceptor stimulation. METHODS The alpha-1 adrenergic agonist phenylephrine or the alpha-2 adrenergic agonist guanfacine was infused into the dorsolateral prefrontal cortex (dlPFC) of monkeys performing the delayed-response (DR) task, a task of SWM, to see how the drugs affect SWM performance. RESULTS Phenylephrine infusion in dlPFC significantly impaired DR performance, whereas guanfacine improved performance. The effects of both drugs were delay-dependent. Infusions outside dlPFC were ineffective. CONCLUSIONS Stimulation of prefrontal cortical alpha-1 adrenoceptors impairs SWM function in monkeys, consistent with the parallel study in rats, whereas stimulation of alpha-2 adrenoceptors improves SWM, indicating that alpha-1 and alpha-2 adrenoceptors may have opposing roles in the PFC.

[1]  A. Arnsten,et al.  Behavioral and receptor binding analysis of the α2-adrenergic agonist, 5-bromo-6 [2-imidazoline-2-YL amino] quinoxaline (UK-14304): evidence for cognitive enhancement at an α2-adrenoceptor subtype , 1991, Neuropharmacology.

[2]  H. E. Rosvold,et al.  Localization of function within the dorsolateral prefrontal cortex of the rhesus monkey. , 1970, Experimental neurology.

[3]  H. Tanila,et al.  The effects of prefrontal intracortical microinjections of an alpha-2 agonist, alpha-2 antagonist and lidocaine on the delayed alternation performance of aged rats , 1996, Brain Research Bulletin.

[4]  A. Arnsten,et al.  Catecholamine regulation of the prefrontal cortex , 1997, Journal of psychopharmacology.

[5]  F. Plum.  Handbook of Physiology. , 1960 .

[6]  J. Jentsch,et al.  The Alpha-1 Adrenergic Agonist, Cirazoline, Impairs Spatial Working Memory Performance in Aged Monkeys , 1997, Pharmacology Biochemistry and Behavior.

[7]  H. Tanila,et al.  Medetomidine, atipamezole, and guanfacine in delayed response performance of aged monkeys , 1996, Pharmacology Biochemistry and Behavior.

[8]  J. Schildkraut.  Biogenic amines and affective disorders. , 1974, Annual review of medicine.

[9]  A. Arnsten.  Behavioral and receptor binding analysis of the α-2 adrenergic agonist, UK-14304 (5 bromo-6 [2-imidazoline-2-yl-amino]quinoxaline): evidence for cognitive enhancement at an α-2 adrenoceptor subtype. , 1991 .

[10]  P. Goldman-Rakic,et al.  Alpha 2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates. , 1985, Science.

[11]  F. Goodwin,et al.  Cerebrospinal fluid norepinephrine in affective illness. , 1978, The American journal of psychiatry.

[12]  S. Kish,et al.  Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder , 1994, Biological Psychiatry.

[13]  C. A. Morgan,et al.  Noradrenergic and serotonergic function in posttraumatic stress disorder. , 1997, Archives of general psychiatry.

[14]  J. Steere,et al.  The α-2A noradrenergic receptor agonist guanfacine improves visual object discrimination reversal performance in aged rhesus monkeys. , 1997 .

[15]  A. Arnsten.  The Biology of Being Frazzled , 1998, Science.

[16]  J. Cai,et al.  Reserpine impairs spatial working memory performance in monkeys: reversal by the α2-adrenergic agonist clonidine , 1993, Brain Research.

[17]  L H Staib,et al.  Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder. , 1997, Archives of general psychiatry.

[18]  A. Arnsten,et al.  Noradrenergic influences on prefrontal cortical cognitive function: opposing actions at postjunctional alpha 1 versus alpha 2-adrenergic receptors. , 1998, Advances in pharmacology.

[19]  Bao-Ming Li,et al.  Delayed-response deficit induced by local injection of the alpha 2-adrenergic antagonist yohimbine into the dorsolateral prefrontal cortex in young adult monkeys. , 1994, Behavioral and neural biology.

[20]  C. A. Morgan,et al.  Noradrenergic Alterations in Posttraumatic Stress Disorder , 1997, Annals of the New York Academy of Sciences.

[21]  JaneR . Taylor,et al.  A role for norepinephrine in stress-induced cognitive deficits: α-1-adrenoceptor mediation in the prefrontal cortex , 1999, Biological Psychiatry.

[22]  F. Goodwin,et al.  Central Norepinephrine Metabolism in Affective Illness: MHPG in the Cerebrospinal Fluid , 1973, Science.

[23]  P. Goldman-Rakic,et al.  The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[24]  J. Krystal,et al.  The biological basis of panic disorder. , 1996, The Journal of clinical psychiatry.

[25]  JaneR . Taylor,et al.  α-1 noradrenergic receptor stimulation impairs prefrontal cortical cognitive function , 1999, Biological Psychiatry.

[26]  A. Arnsten,et al.  The α-2a noradrenergic agonist, guanfacine, improves delayed response performance in young adult rhesus monkeys , 1998, Psychopharmacology.

[27]  R. D. Hunt,et al.  The Contribution of α2-Noradrenergic Mechanisms to Prefrontal Cortical Cognitive Function: Potential Significance for Attention-Deficit Hyperactivity Disorder , 1996 .